Abstract
Attempting to ride on the coattails of botulinum toxin type A (Botox), manufacturers of several cosmeceuticals claim similar or even better efficacy. In this study sponsored by the manufacturer of Botox, 77 women randomly received Botox, placebo, or one of three topical creams for their moderate-to-severe glabellar rhytids. The studied agents were Botox, 20 units total; StriVectin-SD twice daily for 12 weeks; Wrinkle Relax (formerly Faux-Tox) twice daily for 12 weeks; HydroDerm twice daily for 12 weeks; and sterile saline injections. Glabellar wrinkle severity at rest …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
